Limited efficiency of endogenous interleukin-7 levels in T cell reconstitution during HIV-1 infection: Will exogenous interleukin-7 therapy work?

AIDS

Volumn 23, Issue 7, 2009, Pages 745-755

  Rethi, Bence ^a,b   Vivar, Nancy ^a   Sammicheli, Stefano ^a   Chiodi, Francesca ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; B LYMPHOCYTE RECEPTOR; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; FAS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 15; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR ALPHA; KI 67 ANTIGEN; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 7;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL AGING; CELL EXPANSION; CELL SURVIVAL; CLINICAL TRIAL; CYTOKINE PRODUCTION; DIABETES MELLITUS; DOSE RESPONSE; DOWN REGULATION; DRUG MEGADOSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOMODULATION; IMMUNOREGULATION; JOINT DESTRUCTION; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LYMPHOCYTOPENIA; MELANOMA; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SARCOMA; SIMIAN IMMUNODEFICIENCY VIRUS; T CELL DEPLETION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; VIRUS REPLICATION; EDITORIAL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY;

HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-7; T-LYMPHOCYTES;

EID: 67649654090     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283298572     Document Type: Review

References (100)

1. Jiang Q, Li WQ, Aiello FB, Mazzucchelli R, Asefa B, Khaled AR, Durum SK. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev 2005;16:513-533.
2. Fry TJ, Mackall CL. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 2005; 174:6571-6576.
3. Fry TJ, Mackall CL. Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol 2001;22:564-571.
4. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003;4:1191-1198.
5. Li J, Huston G, Swain SL. IL-7 promotes the transition of CD4 effectors to persistent memory cells. J Exp Med 2003; 198:1807-1815.
6. Fry TJ, Connick E, Falloon J, Lederman MM, Liewehr DJ, Spritzler J, et al. A potential role for interleukin-7 in T-cell homeostasis. Blood 2001; 97:2983-2990.
7. Llano A, Barretina J, Gutierrez A, Blanco J, Cabrera C, Clotet B, Este JA. Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncy- tium-inducing variants in human immunodeficiency virus type 1-positive individuals. J Virol 2001;75:10319-10325.
8. Mastroianni CM, Forcina G, d'Ettorre G, Lichtner M, Mengoni F, D'Agostino C, Vullo V. Circulating levels of interleukin-7 in antiretroviral-naive and highly active antiretroviral therapy- treated HIV-infected patients. HIV Clin Trials 2001;2:108- 112.
9. Napolitano LA, Grant RM, DeeksSG, Schmidt D, De Rosa SC, Herzenberg LA, et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001; 7:73-79.
10. Malaspina A, MoirS, Chaitt DG, Rehm CA, Kottilil S, FalloonJ, Fauci AS. Idiopathic CD4R T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood 2007;109:2086-2088.
11. Cox AL, Thompson SA, Jones JL, Robertson VH, Hale G, Waldmann H, et al. Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis. Eur J Immunol 2005;35:3332-3342.
12. Bolotin E, Annett G, Parkman R, Weinberg K. Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant 1999; 23:783-788.
13. Isgro A, Aiuti F, Mezzaroma I, Franchi F, Mazzone AM, Lebba F, Aiuti A. Interleukin 7 production by bone marrow-derived stromal cells in HIV-1-infected patients during highly active antiretroviral therapy. AIDS 2002;16:2231-2232.
14. Paiardini M, Cervasi B, Albrecht H, Muthukumar A, Dunham R, Gordon S, et al. Loss of CD127 expression defines an expansion of effector CD8R T cells in HIV-infected individuals. J Immunol 2005;174:2900-2909.
15. Rethi B, Fluur C, Atlas A, Krzyzowska M, Mowafi F, Grutzmeier S, et al. Loss of IL-7 Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients. AIDS 2005; 19:2077-2086.
16. Sasson SC, ZaundersJJ, Zanetti G, King EM, Merlin KM, Smith DE, et al. Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection. JInfect Dis 2006;193:505-514.
17. Koesters SA, Alimonti JB, Wachihi C, Matu L, Anzala O, Kimani J, etal. IL-7Ralpha expression on CD4R T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation. Eur J Immunol 2006;36:336-344.
18. Resino S, Perez A, Leon JA, Gurbindo MD, Munoz-Fernandez MA. Interleukin-7 levels before highly active antiretroviral therapy may predict CD4R T-cell recovery and virological failure in HIV-infected children. J Antimicrob Chemother 2006; 57:798-800.
19. Ruiz-Mateos E, de la Rosa R, Franco JM, Martinez-Moya M, Rubio A, Soriano N, et al. Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy. AIDS 2003;17:947-954.
20. Beq S, Rannou MT, Fontanet A, Delfraissy JF, Theze J, Colle JH. HIV infection: prehighly active antiretroviral therapy IL-7 plasma levels correlate with long-term CD4 cell count increase after treatment. AIDS 2004; 18:563-565.
21. Mussini C, Pinti M, Borghi V, Nasi M, Amorico G, Monterastelli E, et al. Features of 'CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent anti- retroviral therapy. AIDS 2002; 16:1609-1616.
22. Boulassel MR, Smith GH, Gilmore N, Klein M, Murphy T, MacLeod J, et al. Interleukin-7 levels may predict virological response in advanced HIV-1-infected patients receiving lopinavir/ritonavir-based therapy. HIV Med 2003;4:315-320.
23. Boulassel MR, Samson J, Khammy A, Lapointe N, Soudeyns H, Routy JP. Predictive value of interleukin-7 levels for virological response to treatment in HIV-1-infected children. Viral Immunol 2007; 20:649-656.
24. Muthukumar A, Zhou D, Paiardini M, Barry AP, Cole KS, McClure HM, etal. Timely triggering of homeostatic mechanisms involved in the regulation of T-cell levels in SIVsm- infected sooty mangabeys. Blood 2005;106:3839-3845.
25. Kopka J, Mecikovsky D, Aulicino PC, Mangano AM, Rocco CA, Bologna R, Sen L. High IL-7 plasma levels may induce and predict the emergence of HIV-1 virulent strains in pediatric infection. J Clin Virol 2005;33:237-242.
26. Fluur C, De Milito A, Fry TJ, Vivar N, Eidsmo L, Atlas A, et al. Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infection. J Immunol 2007;178:5340-5350.
27. Jaleco S, Swainson L, Dardalhon V, Burjanadze M, Kinet S, Taylor N. Homeostasis of naive and memory CD4R T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis. J Immunol 2003; 171:61-68.
28. Lelievre JD, Petit F, Arnoult D, Ameisen JC, Estaquier J. Interleukin 7 increases human immunodeficiency virus type 1 LAI-mediated Fas-induced T-cell death. JVirol2005; 79: 3195- 3199.
29. Link A, Vogt TK, Favre S, Britschgi MR, Acha-Orbea H, Hinz B, et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol 2007; 8:12551265.
30. Schacker TW, Nguyen PL, Beilman GJ, Wolinsky S, Larson M, Reilly C, Haase AT. Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. J Clin Invest 2002; 110:1133-1139.
31. Schacker TW, Reilly C, Beilman GJ, Taylor J, Skarda D, Krason D, et al. Amount of lymphatic tissue fibrosis in HIV infection predicts magnitude of HAART-associated change in peripheral CD4 cell count. AIDS 2005;19:2169-2171.
32. Biancotto A, Grivel JC, Iglehart SJ, Vanpouille C, Lisco A, Sieg SF, et al. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 2007;109:4272- 4279.
33. Mazzucchelli R, Durum SK. Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 2007;7:144-154.
34. Golden-Mason L, Burton JR Jr, Castelblanco N, Klarquist J, Benlloch S, Wang C, Rosen HR. Loss of IL-7 receptor alpha- chain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology 2006;44:1098-1109.
35. Kim HR, Hong MS, Dan JM, Kang I. Altered IL-7 Ralpha expression with aging and the potential implications of IL-7 therapy on CD8R T-cell immune responses. Blood 2006;107:2855-2862.
36. Dunham RM, Cervasi B, Brenchley JM, Albrecht H, Weintrob A, Sumpter B, et al. CD127 and CD25 expression defines CD4R T cell subsets that are differentially depleted during HIV infection. J Immunol 2008; 180:5582-5592.
37. Vivar N, Thang PH, Atlas A, Chiodi F, Rethi B. Potential role of CD8+CD28- T lymphocytes in immune activation during HIV-1 infection. AIDS 2008;22:1083-1086.
38. Vassena L, Proschan M, Fauci AS, Lusso P. Interleukin 7 reduces the levels of spontaneous apoptosis in CD4R and CD8R T cells from HIV-1-infected individuals. Proc Natl Acad Sci USA 2007;104:2355-2360.
39. ColleJH, Moreau JL, Fontanet A, Lambotte O, Delfraissy JF, Theze J. The correlation between levels of IL-7Ralpha expression and responsiveness to IL-7 is lost in CD4 lymphocytes from HIV-infected patients. AIDS 2007;21:101-103.
40. Colle JH, Moreau JL, Fontanet A, Lambotte O, Joussemet M, Jacod S, et al. Regulatory dysfunction of the interleukin-7 receptor in CD4 and CD8 lymphocytes from HIV-infected patients: effects of antiretroviral therapy. J Acquir Immune Defic Syndr 2006;42:277-285.
41. Nemes E, Lugli E, Nasi M, Ferraresi R, Pinti M, Bugarini R, etal. Immunophenotype of HIVR patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system. AIDS 2006;20:2021-2032.
42. Faller EM, McVey MJ, Kakal JA, MacPherson PA. Interleukin-7 receptor expression on CD8 T-cells is downregulated by the HIV Tat protein. J Acquir Immune Defic Syndr 2006;43:257-269.
43. Vranjkovic A, Crawley AM, Gee K, Kumar A, Angel JB. IL-7 decreases IL-7 receptor alpha (CD127) expression and induces the shedding of CD127 by human CD8R T cells. Int Immunol 2007;19:1329-1339.
44. Zaunders JJ, Ip S, Munier ML, Kaufmann DE, Suzuki K, Brereton C, et al. Infection of CD127R (interleukin-7 recep- torR) CD4R cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection. J Virol 2006;80:10162-10172.
45. Chene L, Nugeyre MT, Guillemard E, Moulian N, Barre- Sinoussi F, Israel N. Thymocyte-thymic epithelial cell interaction leads to high-level replication of human immunodeficiency virus exclusively in mature CD4(R) CD8(-) CD3(R) thymocytes: a critical role for tumor necrosis factor and interleukin-7. J Virol 1999;73:7533-7542.
46. Steffens CM, Managlia EZ, Landay A, Al-Harthi L. Interleukin- 7-treated naive T cells can be productively infected by T-cell- adapted and primary isolates of human immunodeficiency virus 1. Blood 2002;99:3310-3318.
47. Uittenbogaart CH, Boscardin WJ, Anisman-Posner DJ, Koka PS, Bristol G, Zack JA. Effect of cytokines on HIV-induced depletion of thymocytes in vivo. AIDS 2000;14:1317-1325.
48. Wang FX, Xu Y, Sullivan J, Souder E, Argyris EG, Acheampong EA, et al. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.JClinInvest2005; 115:128-137.
49. Lang KS, Recher M, Navarini AA, Harris NL, Lohning M, Junt T, et al. Inverse correIation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation. Eur J Immunol 2005;35:738-745.
50. Wherry EJ, Barber DL, Kaech SM, Blattman JN, Ahmed R. Antigen-independent memory CD8 T ceIIs do not deveIop during chronic viral infection. Proc Natl Acad Sci USA 2004;101 :16004-16009.
51. Sun JC, Williams MA, Bevan MJ. CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T ceIIs after acute infection. Nat Immunol 2004; 5:927933.
52. Boutboul F, Puthier D, Appay V, Pelle O, Ait-Mohand H, Combadiere B, et al. ModuIation of interIeukin-7 receptor expression characterizes differentiation of CD8 T ceIIs specific for HIV, EBV and CMV. AIDS 2005;19:1981-1986.
53. Wherry EJ, Day CL, Draenert R, Miller JD, Kiepiela P, Woodberry T, et al. HIV-specific CD8 T cells express low levels of IL-7Ralpha: implications for HIV-specific T cell memory. Virology 2006;353:366-373.
54. Pawelec G, Akbar A, Caruso C, Effros R, Grubeck-Loebenstein B, Wikby A. Is immunosenescence infectious? Trends Immunol 2004;25:406-410.
55. Alves NL, van Leeuwen EM, Remmerswaal EB, Vrisekoop N, Tesselaar K, Roosnek E, et al. A new subset of human naive CD8+ T cells defined by low expression of IL-7R alpha. J Immunol 2007;179:221-228.
56. ParkJH, Yu Q, Erman B, Appelbaum JS, Montoya-Durango D, Grimes HL, Singer A. Suppression of IL7RaIpha transcription by IL-7 and other prosurvivaI cytokines: a noveI mechanism for maximizing IL-7-dependent T ceII survivaI. Immunity 2004;21:289-302.
57. Borghesi LA, Yamashita Y, Kincade PW. Heparan suIfate proteogIycans mediate interIeukin-7-dependent B Iympho- poiesis. Blood 1999;93:140-148.
58. Kimura K, Matsubara H, Sogoh S, Kita Y, Sakata T, Nishitani Y, et al. RoIe of gIycosaminogIycans in the reguIation of T ceII proliferation induced by thymic stroma-derived T cell growth factor. J Immunol 1991;146:2618-2624.
59. Beq S, Nugeyre MT, Ho Tsong Fang R, Gautier D, Legrand R, Schmitt N, et al. IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviraI therapy. J Immunol 2006;176:914-922.
60. Nugeyre MT, Monceaux V, Beq S, Cumont MC, Ho Tsong Fang R, Chene L, et al. IL-7 stimuIates T ceII renewaI without increasing viral replication in simian immunodeficiency virus-infected macaques. J Immunol 2003;171:4447-4453.
61. Rosenberg SA, Sportes C, Ahmadzadeh M, Fry TJ, Ngo LT, Schwarz SL, et al. IL-7 administration to humans leads to expansion of CD8+ and CD4+ ceIIs but a reIative decrease of CD4+ T-reguIatory ceIIs. J Immunother 2006; 29:313319.
62. Sportes C, Hakim FT, Memon SA, Zhang H, Chua KS, Brown MR, etal. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferentiaI expansion of naive T ceII subsets. J Exp Med 2008; 205:1701-1714.
63. Munitic I, Williams JA, Yang Y, Dong B, Lucas PJ, El Kassar N, et al. Dynamic reguIation of IL-7 receptor expression is required for normal thymopoiesis. Blood 2004;104:4165-4172.
64. Muthukumar A, Wozniakowski A, Gauduin MC, Paiardini M, McClure HM, Johnson RP, et al. EIevated interIeukin-7 IeveIs not sufficient to maintain T-cell homeostasis during simian immunodeficiency virus-induced disease progression. Blood 2004;103:973-979.
65. FluurC, Rethi B, Thang PH, Vivar N, Mowafi F, Lopalco L, etal. Relationship between serum IL-7 concentrations and lymphopenia upon different levels of HIV immune control. AIDS2007; 21 :1048-1050.
66. MargolickJB, Munoz A, Donnenberg AD, Park LP, Galai N, Giorgi JV, et al. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study. Nat Med 1995;1:674-680.
67. Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B, et al. Upregulation of PD-1 expression on HIV- specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006; 12:1198-1202.
68. Kaufmann DE, Kavanagh DG, Pereyra F, Zaunders JJ, Mackey EW, Miura T, et al. Upregulation of CTLA-4 by HIV-specific CD4(+) T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol 2007;8:1246-1254.
69. Effros RB. Impact of the Hayflick Limit on T cell responses to infection: lessons from aging and HIV disease. Mech Ageing Dev 2004;125:103-106.
70. Papagno L, Spina CA, Marchant A, Salio M, Rufer N, Little S, et al. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol 2004;2:E20.
71. Carini C, McLane MF, Mayer KH, Essex M. Dysregulation of interleukin-7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection. Eur J Immunol 1994; 24:2927-2934.
72. Lipman M, Breen R. Immune reconstitution inflammatory syndrome in HIV. Curr Opin Infect Dis 2006;19:20-25.
73. Krupica T Jr, Fry TJ, Mackall CL. Autoimmunity during lym- phopenia: a two-hit model. Clin Immunol 2006;120:121-128.
74. Albuquerque AS, Cortesao CS, Foxall RB, Soares RS, Victorino RM, Sousa AE. Rate of increase in circulating IL-7 and loss of IL-7Ralpha expression differ in HIV-1 and HIV-2 infections: two lymphopenic diseases with similar hyperimmune activation but distinct outcomes. J Immunol 2007;178:3252-3259.
75. Fry TJ, Moniuszko M, Creekmore S, Donohue SJ, Douek DC, Giardina S, et al. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 2003; 101 :2294-2299.
76. Malaspina A, MoirS, Ho J, WangW, Howell ML, O'Shea MA, et al. Appearance of immature/transitional B cells in HIV- infected individuals with advanced disease: correlation with increased IL-7. Proc Natl Acad Sci USA 2006;103:2262-2267.
77. Unutmaz D, KewalRamani VN, Marmon S, Littman DR. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J Exp Med 1999;189:1735-1746.
78. Jourdan P, Vendrell JP, Huguet MF, Segondy M, Bousquet J, Pene J, Yssel H. Cytokines and cell surface molecules independently induce CXCR4 expression on CD4+ CCR7+ human memory T cells. J Immunol 2000; 165:716-724.
79. Schmitt N, Chene L, Boutolleau D, Nugeyre MT, Guillemard E, Versmisse P, et al. Positive regulation of CXCR4 expression and signaling by interleukin-7 in CD4+ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication. J Virol 2003;77:5784-5793.
80. Scripture-Adams DD, Brooks DG, Korin YD, Zack JA. Inter- leukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. J Virol 2002;76:13077-13082.
81. Stranges PB, Watson J, Cooper CJ, Choisy-Rossi CM, Stonebraker AC, Beighton RA, et al. Elimination of antigen- presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 2007; 26:629-641.
82. BaumlerCB, BohlerT, Herr I, BennerA, KrammerPH, Debatin KM. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood 1996; 88:1741-1746.
83. Boudet F, LecoeurH, Gougeon ML. Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection. J Immunol 1996;156:2282- 2293.
84. Grelli S, Campagna S, Lichtner M, Ricci G, Vella S, Vullo V, et al. Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active antiretroviral therapy. AIDS 2000; 14:939-949.
85. Hosaka N, Oyaizu N, Than S, Pahwa S. Correlation of loss of CD4 T cells with plasma levels of both soluble form Fas (CD95) Fas ligand (FasL) in HIV-infected infants. Clin Immunol 2000; 95:20-25.
86. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA, Herzenberg LA. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 1995;181:2029-2036.
87. Mitra D, Steiner M, Lynch DH, Staiano-Coico L, Laurence J. HIV-1 upregulates Fas ligand expression in CD4+ T cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid. Immunology 1996; 87:581-585.
88. Silvestris F, Cafforio P, Frassanito MA, Tucci M, Romito A, Nagata S, Dammacco F. Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis. AIDS 1996;10:131-141.
89. Li Q, Duan L, Estes JD, Ma ZM, Rourke T, Wang Y, et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005; 434:1148 1152.
90. Brugnoni D, Airo P, Pennacchio M, Carella G, Malagoli A, Ugazio AG, et al. Immune reconstitution after bone marrow transplantation for combined immunodeficiencies: down-modulation of Bcl-2 and high expression of CD95/Fas account for increased susceptibility to spontaneous and activation-induced lymphocyte cell death. Bone Marrow Transplant 1999; 23:451-457.
91. Hakim FT, Cepeda R, Kaimei S, Mackall CL, McAtee N, Zujewski J, et al. Constraints on CD4 recovery postche- motherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 1997; 90:3789-3798.
92. Rethi B, Vivar N, Sammicheli S, FluurC, Ruffin N, Atlas A, etal. Priming of T cells to Fas-mediated proliferative signals by interleukin-7. Blood 2008;112:1195-1204.
93. Murali-Krishna K, Ahmed R. Cutting edge: naive T cells masquerading as memory cells. JImmunol 2000; 165:1733-1737.
94. Ahmadzadeh M, Rosenberg SA. IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. Blood 2006;107:2409-2414.
95. Sereti I, Imamichi H, Natarajan V, Imamichi T, Ramchandani MS, Badralmaa Y, et al. In vivo expansion of CD4CD45RO- CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. J Clin Invest 2005;115:1839-1847.
96. Churchman SM, Ponchel F. Interleukin-7 in rheumatoid arthritis. Rheumatology (Oxford) 2008; 47:753-759.
97. van Roon JA, Lafeber FP. Role ofinterleukin-7 in degenerative and inflammatory joint diseases. Arthritis Res Ther 2008; 10:107.
98. CalzasciaT, Pellegrini M, Lin A, Garza KM, Elford AR, Shahinian A, et al. CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity. Proc Natl Acad Sci USA 2008; 105:2999-3004.
99. Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev 2002;1:329-337.100. Appay V, Rowland-Jones SL. Premature ageing ofthe immune system: the cause of AIDS? Trends Immunol 2002; 23:580 585.
100. OuyangQ, Wagner WM, Wikby A, Walter S, Aubert G, Dodi AI, et al. Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J Clin Immunol 2003; 23:247-257.